O'Connor, D., Moorman, A., Wade, R., Hancock, J., Tan, R., Bartram, J., . . . Samarasinghe, S. (2017). Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia. American Society of Clinical Oncology.
Citação do estilo Chicago (17ª ed.)O'Connor, D., et al. Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia. American Society of Clinical Oncology, 2017.
Citação MLA (9ª ed.)O'Connor, D., et al. Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia. American Society of Clinical Oncology, 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.